Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Even after more than 50 MMPl-icenses we still have the same share price trouble

Pohl and Swartz took the momentum out of this stock by paying out all the cash in dividends. Remember they included warrant holders. RG must rebuild momentum again.



GLTAL



Share
New Message
Please login to post a reply